Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Changes and Challenges for Generic Drugs

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.
Aug 2, 2014

FDA seeks high quality applications and products to facilitate approvals and reduce safety and supply problems.

Industry Seeks Clearer Standards for Track and Trace

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.
Jul 2, 2014

Stakeholders face challenges and benefits from a more secure pharmaceutical supply chain.

Globalization Challenges Drug Regulators

Regulators and industry organizations explain policies and standards to manufacturers and authorities across the globe.
Jun 29, 2014

Regulators and industry organizations explain policies and standards to manufacturers and authorities across the globe.

Global Expansion Shapes Drug Oversight

Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.
Jun 2, 2014

Regulators and industry organizations explain policies and standards to manufacturers and authorities in all regions.

Demand for New Vaccines Spurs Innovation

New formulations and expanded vaccine production are encouraged.
May 2, 2014

New formulations and expanded vaccine production are encouraged.

FDA and Industry Take Action for a More Secure Drug Supply Chain

New identifiers and tracking requirements aim to block illegitimate products.
May 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

FDA and Manufacturers Seek a More Secure Drug Supply Chain

New identifiers and tracking requirements aim to block illegitimate products.
Apr 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development

Accelerated testing and production create challenges in documenting product quality.
Mar 2, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Focuses on Drug Appearance and Attributes

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.
Feb 2, 2014

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here